Lester Michael K.
Known title: President and CEOCIK: 0001864249
Associated companies
Transaction History
| LFST | ▼ Sell | Open Market | 328,615 | $1.8M | 6/13/2022 | View on chart |
| LFST | ▲ Buy | Grant | 289,080 | $0 | 4/25/2022 | View on chart |
| LFST | ▼ Sell | Open Market | 328,615 | $1.8M | 6/13/2022 | View on chart |
| LFST | ▲ Buy | Grant | 289,080 | $0 | 4/25/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.